Hepatoprotective effects of baicalein against liver ischemia-reperfusion injury and partial hepatectomy in a rat model

Mol Biol Rep. 2024 May 10;51(1):643. doi: 10.1007/s11033-024-09548-9.

Abstract

Background: Baicalein is the main active flavonoid in Scutellariae Radix and is included in shosaikoto, a Kampo formula used for treating hepatitis and jaundice. However, little is known about its hepatoprotective effects against hepatic ischemia-reperfusion injury (HIRI), a severe clinical condition directly caused by interventional procedures. We aimed to investigate the hepatoprotective effects of baicalein against HIRI and partial hepatectomy (HIRI + PH) and its potential underlying mechanisms.

Methods and results: Male Sprague-Dawley rats received either baicalein (5 mg/kg) or saline intraperitoneally and underwent a 70% hepatectomy 15 min after hepatic ischemia. After reperfusion, liver and blood samples were collected. Survival was monitored 30 min after hepatic ischemia and hepatectomy. In interleukin 1β (IL-1β)-treated primary cultured rat hepatocytes, the influence of baicalein on inflammatory mediator production and the associated signaling pathway was analyzed. Baicalein suppressed apoptosis and neutrophil infiltration, which are the features of HIRI + PH treatment-induced histological injury. Baicalein also reduced the mRNA expression of the proinflammatory cytokine tumor necrosis factor-α (TNF-α). In addition, HIRI + PH treatment induced liver enzyme deviations in the serum and hypertrophy of the remnant liver, which were suppressed by baicalein. In the lethal HIRI + PH treatment group, baicalein significantly reduced mortality. In IL-1β-treated rat hepatocytes, baicalein suppressed TNF-α and chemokine mRNA expression as well as the activation of nuclear factor-kappa B (NF-κB) and Akt.

Conclusions: Baicalein treatment attenuates HIRI + PH-induced liver injury and may promote survival. This potential hepatoprotection may be partly related to suppressing inflammatory gene induction through the inhibition of NF-κB activity and Akt signaling in hepatocytes.

Keywords: Baicalein; Hepatectomy; Hepatic ischemia-reperfusion injury; Primary cultured hepatocytes.

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Disease Models, Animal*
  • Flavanones* / pharmacology
  • Flavanones* / therapeutic use
  • Hepatectomy* / methods
  • Hepatocytes* / drug effects
  • Hepatocytes* / metabolism
  • Interleukin-1beta* / metabolism
  • Liver* / drug effects
  • Liver* / metabolism
  • Liver* / pathology
  • Male
  • NF-kappa B / metabolism
  • Protective Agents / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Sprague-Dawley*
  • Reperfusion Injury* / drug therapy
  • Reperfusion Injury* / metabolism
  • Signal Transduction / drug effects
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Flavanones
  • baicalein
  • Interleukin-1beta
  • NF-kappa B
  • Protective Agents
  • Tumor Necrosis Factor-alpha
  • Proto-Oncogene Proteins c-akt